# OnCo record nct07487805 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07487805/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07487805", "NCT07487805" ;
  schema:name "ICONIC: ivermectin combined with immune checkpoint inhibition in cancer (University of Florida phase 2)"@en ;
  schema:description "A University of Florida trial will randomise 80 people already on immunotherapy to two doses of ivermectin and measure a change in their immune cells after two weeks. It is not yet open and does not measure whether tumours shrink."@en ;
  schema:url <https://onco.cc/trials/nct07487805/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07487805> ;
  onco:status "planned" ;
  onco:phase "2" ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/drug-repurposing/> ;
  onco:drugs <https://onco.cc/drugs/ivermectin/> ;
  onco:institutions <https://onco.cc/institutions/uf-health-cancer-center/> ;
  onco:terms <https://onco.cc/terms/immune-checkpoint/>, <https://onco.cc/terms/off-label/>, <https://onco.cc/terms/pharmacokinetics/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-generic-repurposing/>, <https://onco.cc/bottlenecks/b-misinformation/> .